OTCPK:LMLLF (Canada)
Business Description
Pharmadrug Inc
NAICS : 325411
SIC : 3741
77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1
Compare
Compare
Traded in other countries / regions
PHRX.Canada
•
G111.Germany
•
LMLLF.USA
Description
Pharmadrug Inc operates as a vertically integrated business in the medical cannabis industry. The company's only segment being the distribution of medical cannabis in Germany. Geographically, it operates in Germany and Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.31 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -0.1 | |||||
| Beneish M-Score | -3.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 59.6 | |||||
| 3-Year EPS without NRI Growth Rate | 60.1 | |||||
| 3-Year FCF Growth Rate | 48.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.7 | |||||
| 9-Day RSI | 50.21 | |||||
| 14-Day RSI | 50.17 | |||||
| 6-1 Month Momentum % | -32.79 | |||||
| 12-1 Month Momentum % | -57.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 0.87 | |||||
| Cash Ratio | 0.48 | |||||
| Days Inventory | 97.19 | |||||
| Days Sales Outstanding | 26.07 | |||||
| Days Payable | 323.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -122.2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.68 | |||||
| Operating Margin % | -1149.13 | |||||
| Net Margin % | -1286.8 | |||||
| ROE % | -33.36 | |||||
| ROA % | -28.87 | |||||
| ROIC % | -26.2 | |||||
| ROC (Joel Greenblatt) % | -7958.92 | |||||
| ROCE % | -33.77 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 33.77 | |||||
| PB Ratio | 0.77 | |||||
| EV-to-EBIT | -1.79 | |||||
| EV-to-EBITDA | -2.22 | |||||
| EV-to-Revenue | 26.42 | |||||
| EV-to-FCF | -3.24 | |||||
| Earnings Yield (Greenblatt) % | -55.66 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with OTCPK:LMLLF
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.367 | ||
| EPS (TTM) ($) | -0.026 | ||
| Beta | 2.61 | ||
| Volatility % | 54.71 | ||
| 14-Day RSI | 50.17 | ||
| 14-Day ATR ($) | 0.003959 | ||
| 20-Day SMA ($) | 0.021993 | ||
| 12-1 Month Momentum % | -57.32 | ||
| 52-Week Range ($) | 0.0144 - 0.07 | ||
| Shares Outstanding (Mil) | 353.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmadrug Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||